Cited by 588Sexual function and dysfunction studiesUrological Disorders and TreatmentsMale Reproductive Health Studies

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population

Rosen, Raymond C., Fisher, William A., Eardley, Ian, Niederberger, Craig, Nadel, Andrea, Sand, Michael·2004·Current Medical Research and Opinion

Abstract

OBJECTIVE: The aims of the Men's Attitudes to Life Events and Sexuality (MALES) study were to identify prevalence of erectile dysfunction (ED) and related health issues in the general male population in Europe, North and South America, and to examine the attitudes and behavior of men in relation to these health issues. RESEARCH DESIGN AND METHODS: Phase I of the MALES study involved 27839 men aged 20-75 years who were interviewed in eight countries (United States, United Kingdom, Germany,France, Italy, Spain, Mexico, and Brazil) using a standardized questionnaire. Phase II of the MALES study involved 2912 men who were recruited from the sub-sample of Phase I MALES participants who reported ED together with additional men with ED recruited from other sources. MAIN OUTCOME MEASURE: Prevalence of ED and associated attitudes. RESULTS: The overall prevalence of ED in the MALES sample was 16%. ED prevalence varied markedly by country, however, from a high of 22%of men in the US reporting ED to a low of 10% in Spain. The prevalence of self-reported ED increased with increasing age. Men with co-morbid medical conditions and risk factors, including cardiovascular disease, hypertension, dyslipidemia,and depression all reported higher prevalence of ED. Men with ED also reported increased prevalence rates of these co-morbid conditions. MALES Phase II data indicated that among men who reported ED, 58% had actively sought medical attention for their condition; however, only 16% of men with ED were currently being treated with oral PDE-5 therapy. CONCLUSIONS: The MALES study confirms the high prevalence rates of ED and its association with co-morbid medical conditions, such as diabetes and depression, reported in other large-scale, epidemiological studies. Despite the advent of oral phosphodiesterase inhibitors, only 58% of ED sufferers consult a physician about their problem, and only 16% of men with self-reported ED maintain their use of oral therapy.

Integrity signals

Registry

Crossref · 10.1185/030079904125003467

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 35 · Cited by 588

Authors
Rosen, R. C., Fisher, W. A., Eardley, I., Niederberger, C., Nadel, A., & Sand, M.
Affiliations
  • Western University (CA)
  • University of Illinois Chicago (US)
Corresponding author
Rosen, Raymond C.
Venue
Current Medical Research and Opinion
Published
2004-03-08
Volume
20
Issue
5
Pages
607-617
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W1999059326
Cited by
588
References
35
Citations by year
2026: 12 · 2025: 18 · 2024: 17 · 2023: 23 · 2022: 12 · 2021: 31 · 2020: 34 · 2019: 30 · 2018: 29 · 2017: 20 · 2016: 15 · 2015: 21 · 2014: 29 · 2013: 32 · 2012: 20
FWCI
23.17
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bayer Corporation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
  • Health Sciences › Health Professions › General Health Professions › Male Reproductive Health Studies
Keywords
erectile dysfunction, prevalence, men's health, comorbidities, cardiovascular disease, hypertension, dyslipidemia, depression, diabetes mellitus, phosphodiesterase-5 inhibitors, treatment seeking, physician consultation, sexual attitudes, age-related prevalence, cross-national comparison
MeSH terms
Adult, Age Factors, Aged, Attitude to Health, Europe, Humans, Erectile Dysfunction, Male, Middle Aged, North America, Phosphodiesterase Inhibitors, Surveys and Questionnaires, Risk Factors, South America, Comorbidity, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review